Tag: Syneos Health
Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with...
MORRISVILLE, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today expanded its...
Syneos Health to Present at Upcoming Investor Conferences
MORRISVILLE, N.C., May 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the...
Syneos Health Announces Pricing of Secondary Offering of Common Stock
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully...
Syneos Health Announces Secondary Offering of Common Stock
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully...
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade...
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health® company, has been recognized with a...
Syneos Health Reports First Quarter 2021 Results
Highlights Revenue of $1,208.7 million for the three months ended March 31, 2021, representing...